Quick Answer
Evolus, Inc. reported Stockholders Equity of -$23.11 million for the year ending 2025.
- Evolus, Inc. showed a decrease of -518.4% in Stockholders Equity from 2024 to 2025.
- This data is from Evolus, Inc.'s annual report (Form 10-K), filed with the SEC on March 3, 2026.
- XBRL data for this metric is available from 2016 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q4 2017: -$75.54 million | Q1 2018: $51.98 million | Q2 2018: $37.93 million | Q3 2018: $94.97 million | Q1 2019: $75.36 million | Q2 2019: $41.18 million | Q3 2019: $17.04 million | Q1 2020: $62.61 million | Q2 2020: $43.60 million | Q3 2020: $35.10 million | Q1 2021: $23.29 million | Q2 2021: $106.14 million | Q3 2021: $97.40 million | Q1 2022: $67.25 million | Q2 2022: $46.86 million | Q3 2022: $29.22 million | Q1 2023: $6.95 million | Q2 2023: -$6.96 million | Q3 2023: -$19.37 million | Q1 2024: $18.44 million | Q2 2024: $19.31 million | Q3 2024: $5.89 million | Q1 2025: -$6.60 million | Q2 2025: -$18.65 million | Q3 2025: -$28.76 million.
- Over the full 10 years of available data (2016 to 2025), Evolus, Inc.'s Stockholders Equity has declined by 225.2%.
- Historical annual values: Fiscal year 2025: -$23.11 million | Fiscal year 2024: $5.52 million | Fiscal year 2023: -$20.69 million | Fiscal year 2022: $18.50 million | Fiscal year 2021: $81.88 million | Fiscal year 2020: -$72.96 million | Fiscal year 2019: $79.46 million | Fiscal year 2018: $84.38 million | Fiscal year 2017: -$75.54 million | Fiscal year 2016: -$7.11 million.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: